People · Operator
Named in public records as an officer, director or promoter · active 2009–2014 · Business Services, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Nephron Pharmaceuticals Corp | — | Business Services | Series C | $75.0M | $1.8B | 2014 |
| Pneumoflex Systems Llc | — | Pharmaceuticals | Pre-Seed | $1.4M | $44.0M | 2009 |
William P. Kennedy at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside William P. Kennedy on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John L. Crysel | 1 | 3 |
| Daniel L Villanueva | 1 | 2 |
| W Robert Addington, II, D.O. | 1 | 1 |
| Robert E. Stephens, Ph.D. | 1 | 1 |
| Wayne P. Rasmussen, Ed D | 1 | 1 |
| Stuart P. Miller, M.D. | 1 | 1 |
| David L. Stevens | 1 | 1 |
| Albert F. Stevens | 1 | 1 |
| Lou Wood Kennedy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.